Compounded Tirzepatide
Dual GIP/GLP-1 receptor agonist for weight management
$285/month
If prescribed by a licensed provider. No hidden fees.
Overview
Compounded tirzepatide is a dual GIP and GLP-1 receptor agonist that may support weight management by targeting two key hormonal pathways involved in appetite regulation and metabolism.
Who Is This For?
Adults seeking weight management support who may benefit from a dual-action approach. Your provider will determine if this treatment is appropriate based on your medical history and health goals.
Potential Benefits
- Targets two hormonal pathways (GIP and GLP-1)
- May help reduce appetite through dual mechanism
- Administered via weekly subcutaneous injection
- Dosage gradually titrated under medical supervision
Important Considerations
- Compounded medications are not FDA-approved
- Common side effects may include nausea, diarrhea, and decreased appetite
- Not suitable for individuals with a history of medullary thyroid carcinoma or MEN 2
- Requires ongoing provider monitoring
- Individual results may vary significantly
Compounded medications are not FDA-approved. All treatments require evaluation and prescription by a licensed healthcare provider. Individual results may vary. This information is not intended to diagnose, treat, cure, or prevent any disease.
Interested in Compounded Tirzepatide?
Connect with a licensed provider to find out if this treatment may be right for you.
Get StartedCompounded Tirzepatide
$285/mo if prescribed